Compass Therapeutics Inc (CMPX) Annual Balance Sheets

Annual · GAAP · USD millions
Access CMPX quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Compass Therapeutics Inc's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent30.64
Marketable Securities, Current SH178.26
Cash & Short-term Investments208.00
Prepaid Expense And Other Assets Current0.91
Total Current Assets209.82
Equipment/Property/Plant Net0.10
Other Assets, Noncurrent9.67
Operating Lease Right Of Use Asset9.10
Total Assets219.59
Liabilities
Accounts Payable, Current AC1.59
Accrued Liabilities, Current AC11.38
Other Liabilities, Current1.00
Total Current Liabilities13.97
Total Long-term Debt0.00
Other liabilities, Noncurrent8.83
OperatingLeaseLiabilityNoncurrent8.83
Operating Lease Liability Current1.00
Total Liabilities22.80
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock627.67
Retained Earnings / Accumulated Deficit-431.17
Other Equity0.28
Common Stockholder's Equity196.79
Total Stockholder's Equity196.79
Liabilities & Stockholder's Equity219.59
4 historic quarters locked

Sign in to unlock the full Compass Therapeutics Inc balance sheet history.

About Compass Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001171843-26-001337

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.